- Home
- / Remedy Plan
Remedy Plan
Total Funding
$10.1 M
Remedy Plan Summary
Company Summary
- Overview
- Remedy Plan Therapeutics is a biotechnology company developing drugs that halt tumor growth and disrupt the cancer stem cells that cause metastasis. It offers a drug screening platform that measures the most dangerous properties of cancer stem cells.
- Type
- Private
- Status
- Active
- Founded
- 2011
- Website
- https://remedyplan.com
- Cybersecurity rating
Table of Contents
Key People
Dennise A. de Jesús-Díaz, Chief Operations Officer
Yushma Bhurruth-Alcor, Director, Medicinal Chemistry